Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 6/20 | 0.60 |
| ▸ | PRKACB | P22694 | 1/20 | 0.58 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.56 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29483770 | 1.00 | GHSR (0.60) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29641173 | 1.00 | GHSR (0.60) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29641066 | 0.96 | GHSR (0.61) | GHSRPRKACBUTS2R | |
| SCHEMBL29641082 | 0.96 | GHSR (0.61) | GHSRPRKACBUTS2R | |
| SCHEMBL29641180 | 0.95 | GHSR (0.58) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29483773 | 0.94 | GHSR (0.56) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29483771 | 0.94 | GHSR (0.56) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL30773914 | 0.94 | GHSR (0.57) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL30118086 | 0.94 | GHSR (0.57) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29389812 | 0.94 | NPY1R (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12558346-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2026-02-24 | — | — | US | claimed |
| US-20250064786-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2025-02-27 | — | — | US | claimed |
| EP-4210695-A1 | METHODS AND COMPOSITIONS FOR DELIVERY OF BIOTIN TO MITOCHONDRIA | Social Profit Network (US) | 2023-07-19 | — | — | EP | claimed |
| US-11389431-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2022-07-19 | — | — | US | claimed |
| WO-2022055811-A1 | METHODS AND COMPOSITIONS FOR DELIVERY OF BIOTIN TO MITOCHONDRIA | SOCIAL PROFIT NETWORK (US) | 2022-03-17 | — | — | WO | claimed |
| US-20220071964-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2022-03-10 | — | — | US | claimed |
| US-12558346-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250064786-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2025-02-27 | — | — | US | disclosed |
| US-12150932-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2024-11-26 | — | — | US | disclosed |
| US-11801235-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230226026-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-07-20 | — | — | US | disclosed |
| EP-4210695-A1 | METHODS AND COMPOSITIONS FOR DELIVERY OF BIOTIN TO MITOCHONDRIA | Social Profit Network (US) | 2023-07-19 | — | — | EP | disclosed |
| US-20230210824-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-07-06 | — | — | US | disclosed |
| US-11617739-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-04-04 | — | — | US | disclosed |
| US-11602523-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230043530-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2023-02-09 | — | — | US | disclosed |
| US-20220347160-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2022-11-03 | — | — | US | disclosed |
| US-11389431-B2 | Methods and compositions for delivery of biotin to mitochondria | SOCIAL PROFIT NETWORK (US) | 2022-07-19 | — | — | US | disclosed |
| WO-2022055811-A1 | METHODS AND COMPOSITIONS FOR DELIVERY OF BIOTIN TO MITOCHONDRIA | SOCIAL PROFIT NETWORK (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220071964-A1 | Methods and Compositions for Delivery of Biotin to Mitochondria | SOCIAL PROFIT NETWORK (US) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558346-B2 | Methods and compositions for delivery of biotin to mitochondria | PDF, MARS2, NLN | GHSR 4206/4885PRKACB 4742/4885UTS2R 4162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.